26 Marzo 2019


Prenatalsafe test in Ecomedica

25-03-2014 09:52 - News Generiche
Is now available at Ecomedica analysis laboratory the prenatalSafe test, a new fetal DNA testing from maternal blood sample.
This test , developed by an Italian laboratory , promises , with almost complete certainty and with a simple test of the mother blood , to identify, through the direct analysis of fetal DNA in maternal blood , Down syndrome and other chromosomal abnormalities such as Edwards syndrome (trisomy 18 , 1 case out of 6000 births) and Patau syndrome ( trisomy 13 , 1 case on 10 thousand ), Turner's syndrome ( monosomy X) , Klinefelter 's syndrome and the syndrome of Jacobs.
The test also gives the opportunity to investigate other chromosomal abnormalities such the traditional chromosomes 5 , verifying the presence of structural chromosomal alterations and sub- microscopic , such as DiGeorge syndrome , Cri -du -chat or Prader-Willi/Angelman .

The advantages ? No risk to the fetus , reliability higher than 99% and , especially , the practicality of samples that should no longer travel to foreign laboratories to be analyzed . Unlike other tests available for some time , in fact, with PrenatalSafe samples are no longer sent to laboratories Americans or Chinese, but directly analyzed and reported in Italy. An advantage not to be underestimated , which allows to significantly reduce the time of response , not exceeding seven working days , and the risk that the samples deteriorate , subjected to long trips.
PrenatalSafe is executable in both single and twins pregnancies , although obtained with assisted reproductive technology . The test is indicated when maternal age is advanced (over 35 years), in the case of first-trimester screening (Bi- Test) positive ultrasound picture of fetal abnormalities suggestive of aneuploidy , for all pregnancies in which it is contraindicated invasive prenatal diagnosis or when there is a history of personal / family of chromosomal abnormalities , as suggested by the guidelines recently issued by the American College of Obstetricians and Gynecologist and the Society for Maternal Fetal Medicine .
In brief, the test PrenatalSafe is:


It 'requires a simple blood sample of the mother , from which analyzes fetal DNA circulating.


It ' a non-invasive test , are then reset the risks of abortion present in the traditional techniques of invasive prenatal diagnosis such as amniocentesis and chorionic villus sampling .


Has an accuracy of more than 99 % to detect trisomy 21 , trisomy 18 and trisomy 13 , and 95% to detect the monosomy X , with the percentage of false positives <0.1 % .


PrenatalSAFE ® is the ONLY non-invasive prenatal test that is performed entirely in ITALY , in the laboratories of the Group GENOME . Unlike other centers in Italy that offer similar test , the samples are NOT sent in service laboratories located in the U.S. or China


PrenatalSAFE ® is the ONLY non-invasive prenatal test that provides results in terms of POSITIVE or NEGATIVE , ie, presence / absence of aneuploidy , chromosomal , and not in terms of percentage of risk (high / low risk ) , as similar tests proposed by other centers.

[Realizzazione siti web www.sitoper.it]
The product has been added to your basket

continue shopping
Request the product
Enter your email address to be notified when the product will be available again.

Request for availability sent
Availability request not sent